nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisacodyl—Anorectal discomfort—Etoposide—uterine cancer	0.0388	0.0388	CcSEcCtD
Bisacodyl—Haematochezia—Epirubicin—uterine cancer	0.0295	0.0295	CcSEcCtD
Bisacodyl—Haematochezia—Doxorubicin—uterine cancer	0.0273	0.0273	CcSEcCtD
Bisacodyl—Cramp muscle—Progesterone—uterine cancer	0.0271	0.0271	CcSEcCtD
Bisacodyl—Abdominal discomfort—Progesterone—uterine cancer	0.0249	0.0249	CcSEcCtD
Bisacodyl—Cramp muscle—Medroxyprogesterone Acetate—uterine cancer	0.0245	0.0245	CcSEcCtD
Bisacodyl—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.0226	0.0226	CcSEcCtD
Bisacodyl—Anorectal discomfort—Epirubicin—uterine cancer	0.0217	0.0217	CcSEcCtD
Bisacodyl—Anorectal discomfort—Doxorubicin—uterine cancer	0.0201	0.0201	CcSEcCtD
Bisacodyl—Immune system disorder—Progesterone—uterine cancer	0.0188	0.0188	CcSEcCtD
Bisacodyl—Malnutrition—Progesterone—uterine cancer	0.0181	0.0181	CcSEcCtD
Bisacodyl—Muscle spasms—Progesterone—uterine cancer	0.0174	0.0174	CcSEcCtD
Bisacodyl—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.017	0.017	CcSEcCtD
Bisacodyl—Angioedema—Progesterone—uterine cancer	0.0166	0.0166	CcSEcCtD
Bisacodyl—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.0164	0.0164	CcSEcCtD
Bisacodyl—Syncope—Progesterone—uterine cancer	0.0162	0.0162	CcSEcCtD
Bisacodyl—Loss of consciousness—Progesterone—uterine cancer	0.0159	0.0159	CcSEcCtD
Bisacodyl—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.0158	0.0158	CcSEcCtD
Bisacodyl—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.015	0.015	CcSEcCtD
Bisacodyl—Anaphylactic shock—Progesterone—uterine cancer	0.0148	0.0148	CcSEcCtD
Bisacodyl—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.0147	0.0147	CcSEcCtD
Bisacodyl—Shock—Progesterone—uterine cancer	0.0145	0.0145	CcSEcCtD
Bisacodyl—Nervous system disorder—Progesterone—uterine cancer	0.0145	0.0145	CcSEcCtD
Bisacodyl—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.0144	0.0144	CcSEcCtD
Bisacodyl—Cramp muscle—Etoposide—uterine cancer	0.0139	0.0139	CcSEcCtD
Bisacodyl—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.0134	0.0134	CcSEcCtD
Bisacodyl—Shock—Medroxyprogesterone Acetate—uterine cancer	0.0132	0.0132	CcSEcCtD
Bisacodyl—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.0131	0.0131	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Progesterone—uterine cancer	0.0128	0.0128	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Progesterone—uterine cancer	0.0121	0.0121	CcSEcCtD
Bisacodyl—Abdominal pain—Progesterone—uterine cancer	0.0117	0.0117	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.0116	0.0116	CcSEcCtD
Bisacodyl—Colitis—Epirubicin—uterine cancer	0.0114	0.0114	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.011	0.011	CcSEcCtD
Bisacodyl—Hypersensitivity—Progesterone—uterine cancer	0.0109	0.0109	CcSEcCtD
Bisacodyl—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.0106	0.0106	CcSEcCtD
Bisacodyl—Colitis—Doxorubicin—uterine cancer	0.0106	0.0106	CcSEcCtD
Bisacodyl—Diarrhoea—Progesterone—uterine cancer	0.0101	0.0101	CcSEcCtD
Bisacodyl—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00987	0.00987	CcSEcCtD
Bisacodyl—Dizziness—Progesterone—uterine cancer	0.00978	0.00978	CcSEcCtD
Bisacodyl—Immune system disorder—Etoposide—uterine cancer	0.00962	0.00962	CcSEcCtD
Bisacodyl—Vomiting—Progesterone—uterine cancer	0.0094	0.0094	CcSEcCtD
Bisacodyl—Headache—Progesterone—uterine cancer	0.00926	0.00926	CcSEcCtD
Bisacodyl—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00917	0.00917	CcSEcCtD
Bisacodyl—Muscle spasms—Etoposide—uterine cancer	0.00891	0.00891	CcSEcCtD
Bisacodyl—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00886	0.00886	CcSEcCtD
Bisacodyl—Nausea—Progesterone—uterine cancer	0.00878	0.00878	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00855	0.00855	CcSEcCtD
Bisacodyl—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00852	0.00852	CcSEcCtD
Bisacodyl—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00839	0.00839	CcSEcCtD
Bisacodyl—Abdominal pain—Dactinomycin—uterine cancer	0.00826	0.00826	CcSEcCtD
Bisacodyl—Loss of consciousness—Etoposide—uterine cancer	0.00815	0.00815	CcSEcCtD
Bisacodyl—Dehydration—Epirubicin—uterine cancer	0.00802	0.00802	CcSEcCtD
Bisacodyl—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00796	0.00796	CcSEcCtD
Bisacodyl—Hypersensitivity—Dactinomycin—uterine cancer	0.0077	0.0077	CcSEcCtD
Bisacodyl—Anaphylactic shock—Etoposide—uterine cancer	0.00756	0.00756	CcSEcCtD
Bisacodyl—Dehydration—Doxorubicin—uterine cancer	0.00742	0.00742	CcSEcCtD
Bisacodyl—Diarrhoea—Dactinomycin—uterine cancer	0.00715	0.00715	CcSEcCtD
Bisacodyl—Vomiting—Dactinomycin—uterine cancer	0.00664	0.00664	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Etoposide—uterine cancer	0.00653	0.00653	CcSEcCtD
Bisacodyl—Nausea—Dactinomycin—uterine cancer	0.00621	0.00621	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Etoposide—uterine cancer	0.00618	0.00618	CcSEcCtD
Bisacodyl—Abdominal pain—Etoposide—uterine cancer	0.00598	0.00598	CcSEcCtD
Bisacodyl—Hypersensitivity—Etoposide—uterine cancer	0.00557	0.00557	CcSEcCtD
Bisacodyl—Immune system disorder—Epirubicin—uterine cancer	0.00539	0.00539	CcSEcCtD
Bisacodyl—Malnutrition—Epirubicin—uterine cancer	0.00519	0.00519	CcSEcCtD
Bisacodyl—Diarrhoea—Etoposide—uterine cancer	0.00518	0.00518	CcSEcCtD
Bisacodyl—Dizziness—Etoposide—uterine cancer	0.005	0.005	CcSEcCtD
Bisacodyl—Muscle spasms—Epirubicin—uterine cancer	0.00499	0.00499	CcSEcCtD
Bisacodyl—Immune system disorder—Doxorubicin—uterine cancer	0.00499	0.00499	CcSEcCtD
Bisacodyl—Vomiting—Etoposide—uterine cancer	0.00481	0.00481	CcSEcCtD
Bisacodyl—Malnutrition—Doxorubicin—uterine cancer	0.00481	0.00481	CcSEcCtD
Bisacodyl—Headache—Etoposide—uterine cancer	0.00474	0.00474	CcSEcCtD
Bisacodyl—Syncope—Epirubicin—uterine cancer	0.00466	0.00466	CcSEcCtD
Bisacodyl—Muscle spasms—Doxorubicin—uterine cancer	0.00462	0.00462	CcSEcCtD
Bisacodyl—Loss of consciousness—Epirubicin—uterine cancer	0.00457	0.00457	CcSEcCtD
Bisacodyl—Nausea—Etoposide—uterine cancer	0.00449	0.00449	CcSEcCtD
Bisacodyl—Syncope—Doxorubicin—uterine cancer	0.00431	0.00431	CcSEcCtD
Bisacodyl—Anaphylactic shock—Epirubicin—uterine cancer	0.00424	0.00424	CcSEcCtD
Bisacodyl—Loss of consciousness—Doxorubicin—uterine cancer	0.00422	0.00422	CcSEcCtD
Bisacodyl—Shock—Epirubicin—uterine cancer	0.00417	0.00417	CcSEcCtD
Bisacodyl—Nervous system disorder—Epirubicin—uterine cancer	0.00416	0.00416	CcSEcCtD
Bisacodyl—Anaphylactic shock—Doxorubicin—uterine cancer	0.00392	0.00392	CcSEcCtD
Bisacodyl—Shock—Doxorubicin—uterine cancer	0.00386	0.00386	CcSEcCtD
Bisacodyl—Nervous system disorder—Doxorubicin—uterine cancer	0.00385	0.00385	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00366	0.00366	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Epirubicin—uterine cancer	0.00347	0.00347	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.00339	0.00339	CcSEcCtD
Bisacodyl—Abdominal pain—Epirubicin—uterine cancer	0.00335	0.00335	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00321	0.00321	CcSEcCtD
Bisacodyl—Hypersensitivity—Epirubicin—uterine cancer	0.00312	0.00312	CcSEcCtD
Bisacodyl—Abdominal pain—Doxorubicin—uterine cancer	0.0031	0.0031	CcSEcCtD
Bisacodyl—Diarrhoea—Epirubicin—uterine cancer	0.0029	0.0029	CcSEcCtD
Bisacodyl—Hypersensitivity—Doxorubicin—uterine cancer	0.00289	0.00289	CcSEcCtD
Bisacodyl—Dizziness—Epirubicin—uterine cancer	0.0028	0.0028	CcSEcCtD
Bisacodyl—Vomiting—Epirubicin—uterine cancer	0.0027	0.0027	CcSEcCtD
Bisacodyl—Diarrhoea—Doxorubicin—uterine cancer	0.00268	0.00268	CcSEcCtD
Bisacodyl—Headache—Epirubicin—uterine cancer	0.00266	0.00266	CcSEcCtD
Bisacodyl—Dizziness—Doxorubicin—uterine cancer	0.00259	0.00259	CcSEcCtD
Bisacodyl—Nausea—Epirubicin—uterine cancer	0.00252	0.00252	CcSEcCtD
Bisacodyl—Vomiting—Doxorubicin—uterine cancer	0.00249	0.00249	CcSEcCtD
Bisacodyl—Headache—Doxorubicin—uterine cancer	0.00246	0.00246	CcSEcCtD
Bisacodyl—Nausea—Doxorubicin—uterine cancer	0.00233	0.00233	CcSEcCtD
